| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 2.74e-05 | 11 | 112 | 3 | GO:0005388 | |
| GeneOntologyMolecularFunction | calcium-dependent ATPase activity | 1.86e-04 | 4 | 112 | 2 | GO:0030899 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 3.28e-04 | 231 | 112 | 7 | GO:0005085 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 4.07e-04 | 62 | 112 | 4 | GO:0019829 | |
| GeneOntologyMolecularFunction | eukaryotic translation initiation factor 2alpha kinase activity | 4.61e-04 | 6 | 112 | 2 | GO:0004694 | |
| GeneOntologyBiologicalProcess | endoplasmic reticulum calcium ion homeostasis | 1.53e-05 | 29 | 108 | 4 | GO:0032469 | |
| GeneOntologyBiologicalProcess | growth hormone receptor signaling pathway via JAK-STAT | 1.63e-05 | 10 | 108 | 3 | GO:0060397 | |
| GeneOntologyBiologicalProcess | response to interleukin-2 | 2.23e-05 | 11 | 108 | 3 | GO:0070669 | |
| GeneOntologyBiologicalProcess | calcium ion transport from cytosol to endoplasmic reticulum | 2.72e-05 | 2 | 108 | 2 | GO:1903515 | |
| GeneOntologyBiologicalProcess | intracellular transport | USP9X GNPTAB GRAMD1A INPP5F LYST STAT3 STX12 TBC1D20 SCYL2 EIF4ENIF1 XPO6 CD36 TRAPPC6B SYNE2 ITSN2 AKAP13 TOMM40 ATP2A1 ATP2A2 ATP2A3 NOTCH1 | 2.79e-05 | 1496 | 108 | 21 | GO:0046907 |
| GeneOntologyBiologicalProcess | response to interleukin-15 | 2.97e-05 | 12 | 108 | 3 | GO:0070672 | |
| GeneOntologyBiologicalProcess | response to interleukin-4 | 6.20e-05 | 41 | 108 | 4 | GO:0070670 | |
| GeneOntologyBiologicalProcess | development of secondary male sexual characteristics | 8.12e-05 | 3 | 108 | 2 | GO:0046544 | |
| GeneOntologyBiologicalProcess | positive regulation of endoplasmic reticulum calcium ion concentration | 8.12e-05 | 3 | 108 | 2 | GO:0032470 | |
| GeneOntologyBiologicalProcess | muscle system process | DOCK4 MAP2K4 HTR2A INPP5F CMYA5 MYOF CTNNA3 AKAP13 ATP2A1 ATP2A2 NOTCH1 | 1.40e-04 | 547 | 108 | 11 | GO:0003012 |
| GeneOntologyBiologicalProcess | clathrin-dependent endocytosis | 1.71e-04 | 53 | 108 | 4 | GO:0072583 | |
| GeneOntologyBiologicalProcess | regulation of stem cell differentiation | 1.73e-04 | 99 | 108 | 5 | GO:2000736 | |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 1.23e-05 | 9 | 112 | 3 | GO:0031095 | |
| GeneOntologyCellularComponent | platelet dense tubular network | 2.39e-05 | 11 | 112 | 3 | GO:0031094 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 9.82e-05 | 45 | 112 | 4 | GO:0033017 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 1.11e-04 | 88 | 112 | 5 | GO:0016529 | |
| GeneOntologyCellularComponent | sarcoplasm | 3.72e-04 | 114 | 112 | 5 | GO:0016528 | |
| Domain | P-type_ATPase_IIA | 1.93e-07 | 3 | 109 | 3 | IPR005782 | |
| Domain | STAT_TF_DNA-bd_sub | 6.65e-06 | 7 | 109 | 3 | IPR012345 | |
| Domain | STAT | 6.65e-06 | 7 | 109 | 3 | IPR001217 | |
| Domain | STAT_int | 6.65e-06 | 7 | 109 | 3 | SM00964 | |
| Domain | STAT_TF_DNA-bd | 6.65e-06 | 7 | 109 | 3 | IPR013801 | |
| Domain | STAT_bind | 6.65e-06 | 7 | 109 | 3 | PF02864 | |
| Domain | STAT_int | 6.65e-06 | 7 | 109 | 3 | PF02865 | |
| Domain | - | 6.65e-06 | 7 | 109 | 3 | 1.10.532.10 | |
| Domain | STAT_alpha | 6.65e-06 | 7 | 109 | 3 | PF01017 | |
| Domain | - | 6.65e-06 | 7 | 109 | 3 | 1.20.1050.20 | |
| Domain | STAT_TF_prot_interaction | 6.65e-06 | 7 | 109 | 3 | IPR013799 | |
| Domain | STAT_TF_coiled-coil | 6.65e-06 | 7 | 109 | 3 | IPR015988 | |
| Domain | - | 6.65e-06 | 7 | 109 | 3 | 2.60.40.630 | |
| Domain | STAT_TF_alpha | 1.06e-05 | 8 | 109 | 3 | IPR013800 | |
| Domain | Hydrolase_3 | 2.25e-05 | 10 | 109 | 3 | PF08282 | |
| Domain | - | 8.36e-05 | 15 | 109 | 3 | 1.10.1000.11 | |
| Domain | Sec7 | 8.36e-05 | 15 | 109 | 3 | PF01369 | |
| Domain | Sec7_alpha_orthog | 8.36e-05 | 15 | 109 | 3 | IPR023394 | |
| Domain | SEC7 | 1.02e-04 | 16 | 109 | 3 | PS50190 | |
| Domain | ATPase_P-typ_TM_dom | 1.02e-04 | 16 | 109 | 3 | IPR023298 | |
| Domain | Sec7 | 1.02e-04 | 16 | 109 | 3 | SM00222 | |
| Domain | - | 1.02e-04 | 16 | 109 | 3 | 1.20.1110.10 | |
| Domain | Sec7_dom | 1.02e-04 | 16 | 109 | 3 | IPR000904 | |
| Domain | ATPase_P-typ_cation-transptr_C | 1.24e-04 | 17 | 109 | 3 | IPR006068 | |
| Domain | Cation_ATPase_C | 1.24e-04 | 17 | 109 | 3 | PF00689 | |
| Domain | Cation_ATPase_N | 1.48e-04 | 18 | 109 | 3 | PF00690 | |
| Domain | Cation_ATPase_N | 1.48e-04 | 18 | 109 | 3 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 1.75e-04 | 19 | 109 | 3 | IPR004014 | |
| Domain | EF-hand-dom_pair | 2.80e-04 | 287 | 109 | 8 | IPR011992 | |
| Domain | LNR | 3.34e-04 | 5 | 109 | 2 | PS50258 | |
| Domain | PH | 3.93e-04 | 229 | 109 | 7 | PF00169 | |
| Domain | Notch_dom | 6.95e-04 | 7 | 109 | 2 | IPR000800 | |
| Domain | Notch | 6.95e-04 | 7 | 109 | 2 | PF00066 | |
| Domain | NL | 6.95e-04 | 7 | 109 | 2 | SM00004 | |
| Domain | ARM-type_fold | 8.41e-04 | 339 | 109 | 8 | IPR016024 | |
| Domain | - | 8.48e-04 | 32 | 109 | 3 | 3.40.1110.10 | |
| Domain | - | 8.48e-04 | 32 | 109 | 3 | 2.70.150.10 | |
| Domain | - | 8.52e-04 | 261 | 109 | 7 | 1.10.238.10 | |
| Domain | PH_dom-like | 8.76e-04 | 426 | 109 | 9 | IPR011993 | |
| Domain | C2 | 1.03e-03 | 131 | 109 | 5 | PF00168 | |
| Domain | ATPase_P-typ_cyto_domN | 1.10e-03 | 35 | 109 | 3 | IPR023299 | |
| Domain | ATPase_P-typ_P_site | 1.20e-03 | 36 | 109 | 3 | IPR018303 | |
| Domain | P_typ_ATPase | 1.20e-03 | 36 | 109 | 3 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 1.20e-03 | 36 | 109 | 3 | PS00154 | |
| Domain | PH | 1.23e-03 | 278 | 109 | 7 | SM00233 | |
| Domain | C2 | 1.25e-03 | 137 | 109 | 5 | SM00239 | |
| Domain | PH_DOMAIN | 1.25e-03 | 279 | 109 | 7 | PS50003 | |
| Domain | PH_domain | 1.28e-03 | 280 | 109 | 7 | IPR001849 | |
| Domain | ATPase_P-typ_transduc_dom_A | 1.30e-03 | 37 | 109 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 1.30e-03 | 37 | 109 | 3 | PF00122 | |
| Domain | C2 | 1.47e-03 | 142 | 109 | 5 | PS50004 | |
| Domain | SH3_2 | 1.61e-03 | 86 | 109 | 4 | PF07653 | |
| Domain | SH3_2 | 1.61e-03 | 86 | 109 | 4 | IPR011511 | |
| Domain | - | 1.76e-03 | 148 | 109 | 5 | 2.60.40.150 | |
| Domain | EF-hand_1 | 1.98e-03 | 152 | 109 | 5 | PF00036 | |
| Domain | - | 2.08e-03 | 391 | 109 | 8 | 2.30.29.30 | |
| Domain | WWE | 2.14e-03 | 12 | 109 | 2 | PF02825 | |
| Domain | WWE-dom | 2.14e-03 | 12 | 109 | 2 | IPR004170 | |
| Domain | WWE | 2.14e-03 | 12 | 109 | 2 | PS50918 | |
| Domain | Sulfotransfer_2 | 2.14e-03 | 12 | 109 | 2 | PF03567 | |
| Domain | Sulfotransferase | 2.14e-03 | 12 | 109 | 2 | IPR005331 | |
| Domain | Recoverin | 2.52e-03 | 13 | 109 | 2 | IPR028846 | |
| Domain | C2_dom | 2.75e-03 | 164 | 109 | 5 | IPR000008 | |
| Domain | EGF-like_dom | 3.41e-03 | 249 | 109 | 6 | IPR000742 | |
| Domain | Helicase_C | 3.57e-03 | 107 | 109 | 4 | PF00271 | |
| Domain | HELICc | 3.57e-03 | 107 | 109 | 4 | SM00490 | |
| Domain | p53-like_TF_DNA-bd | 3.66e-03 | 53 | 109 | 3 | IPR008967 | |
| Domain | Helicase_C | 3.69e-03 | 108 | 109 | 4 | IPR001650 | |
| Domain | HELICASE_CTER | 3.82e-03 | 109 | 109 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 3.82e-03 | 109 | 109 | 4 | PS51192 | |
| Domain | DEXDc | 3.82e-03 | 109 | 109 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 3.94e-03 | 110 | 109 | 4 | IPR014001 | |
| Domain | ARM-like | 5.06e-03 | 270 | 109 | 6 | IPR011989 | |
| Pathway | WP_PDGFRBETA_PATHWAY | 1.48e-08 | 29 | 83 | 6 | M39616 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_JAK_STAT_SIGNALING_PATHWAY | 1.95e-06 | 5 | 83 | 3 | M48987 | |
| Pathway | REACTOME_SIGNALING_BY_CYTOSOLIC_FGFR1_FUSION_MUTANTS | 3.21e-06 | 18 | 83 | 4 | M673 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 3.21e-06 | 18 | 83 | 4 | M614 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 3.89e-06 | 6 | 83 | 3 | MM15581 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 3.89e-06 | 6 | 83 | 3 | MM15621 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_JAK_STAT_SIGNALING_PATHWAY | 6.77e-06 | 7 | 83 | 3 | M47430 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_SERCA | 1.08e-05 | 8 | 83 | 3 | M47955 | |
| Pathway | BIOCARTA_TPO_PATHWAY | 1.09e-05 | 24 | 83 | 4 | M11520 | |
| Pathway | BIOCARTA_TPO_PATHWAY | 1.29e-05 | 25 | 83 | 4 | MM1519 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 1.61e-05 | 9 | 83 | 3 | M27861 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 1.61e-05 | 9 | 83 | 3 | MM1419 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 1.61e-05 | 9 | 83 | 3 | M8066 | |
| Pathway | BIOCARTA_EGF_PATHWAY | 1.77e-05 | 27 | 83 | 4 | M1909 | |
| Pathway | BIOCARTA_EGF_PATHWAY | 2.05e-05 | 28 | 83 | 4 | MM1386 | |
| Pathway | BIOCARTA_PDGF_PATHWAY | 2.05e-05 | 28 | 83 | 4 | M2529 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 2.29e-05 | 10 | 83 | 3 | M27898 | |
| Pathway | BIOCARTA_PDGF_PATHWAY | 2.37e-05 | 29 | 83 | 4 | MM1452 | |
| Pathway | REACTOME_FGFR1_MUTANT_RECEPTOR_ACTIVATION | 3.11e-05 | 31 | 83 | 4 | M661 | |
| Pathway | REACTOME_SIGNALING_BY_LEPTIN | 3.14e-05 | 11 | 83 | 3 | M27195 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 3.14e-05 | 11 | 83 | 3 | MM15578 | |
| Pathway | BIOCARTA_ARAP_PATHWAY | 4.17e-05 | 12 | 83 | 3 | MM1342 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 4.17e-05 | 12 | 83 | 3 | M27326 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 6.84e-05 | 14 | 83 | 3 | MM15052 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 6.84e-05 | 14 | 83 | 3 | M27858 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR1_IN_DISEASE | 7.08e-05 | 38 | 83 | 4 | M27536 | |
| Pathway | WP_FOXP3_IN_COVID19 | 8.51e-05 | 15 | 83 | 3 | M42573 | |
| Pathway | REACTOME_INTERLEUKIN_7_SIGNALING | 8.51e-05 | 15 | 83 | 3 | MM14536 | |
| Pathway | PID_TCPTP_PATHWAY | 1.05e-04 | 42 | 83 | 4 | M91 | |
| Pathway | PID_PDGFRB_PATHWAY | 1.11e-04 | 129 | 83 | 6 | M186 | |
| Pathway | BIOCARTA_ARAP_PATHWAY | 1.26e-04 | 17 | 83 | 3 | M2482 | |
| Pathway | WP_IL9_SIGNALING | 1.26e-04 | 17 | 83 | 3 | M39644 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HORMONE_LIKE_CYTOKINE_TO_JAK_STAT_SIGNALING_PATHWAY | 1.26e-04 | 17 | 83 | 3 | M47905 | |
| Pathway | REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING | 2.09e-04 | 20 | 83 | 3 | MM15496 | |
| Pathway | REACTOME_SIGNALING_BY_KIT_IN_DISEASE | 2.09e-04 | 20 | 83 | 3 | M39002 | |
| Pathway | PID_IL2_1PATHWAY | 3.03e-04 | 55 | 83 | 4 | M122 | |
| Pathway | BIOCARTA_GLEEVEC_PATHWAY | 3.20e-04 | 23 | 83 | 3 | MM1424 | |
| Pathway | BIOCARTA_GLEEVEC_PATHWAY | 3.20e-04 | 23 | 83 | 3 | M7897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IL2_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY | 3.20e-04 | 23 | 83 | 3 | M47904 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_JAK_STAT_SIGNALING_PATHWAY | 3.39e-04 | 5 | 83 | 2 | M48986 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PRL_JAK_STAT_SIGNALING_PATHWAY | 3.39e-04 | 5 | 83 | 2 | M49006 | |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 3.64e-04 | 24 | 83 | 3 | M519 | |
| Pathway | WP_KIT_RECEPTOR_SIGNALING | 3.97e-04 | 59 | 83 | 4 | M39350 | |
| Pathway | REACTOME_INACTIVATION_OF_CSF3_G_CSF_SIGNALING | 4.12e-04 | 25 | 83 | 3 | M41829 | |
| Pathway | WP_IL7_SIGNALING | 4.12e-04 | 25 | 83 | 3 | M39499 | |
| Pathway | REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING | 4.64e-04 | 26 | 83 | 3 | M27750 | |
| Pathway | WP_EPO_RECEPTOR_SIGNALING | 4.64e-04 | 26 | 83 | 3 | M39687 | |
| Pathway | WP_EPO_RECEPTOR_SIGNALING | 4.64e-04 | 26 | 83 | 3 | MM15896 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_B_RECEPTORS | 5.06e-04 | 6 | 83 | 2 | M27220 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR_IN_DISEASE | 5.11e-04 | 63 | 83 | 4 | M635 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 5.20e-04 | 27 | 83 | 3 | MM15053 | |
| Pathway | BIOCARTA_GH_PATHWAY | 5.20e-04 | 27 | 83 | 3 | M9043 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION | 5.20e-04 | 27 | 83 | 3 | MM14712 | |
| Pathway | WP_ONCOSTATIN_M_SIGNALING | 5.76e-04 | 65 | 83 | 4 | M39562 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 5.80e-04 | 28 | 83 | 3 | M924 | |
| Pathway | WP_AGERAGE_PATHWAY | 6.10e-04 | 66 | 83 | 4 | M39420 | |
| Pathway | BIOCARTA_BIOPEPTIDES_PATHWAY | 6.44e-04 | 29 | 83 | 3 | MM1356 | |
| Pathway | BIOCARTA_BIOPEPTIDES_PATHWAY | 6.44e-04 | 29 | 83 | 3 | M13494 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION | 6.44e-04 | 29 | 83 | 3 | M779 | |
| Pathway | WP_IL5_SIGNALING_PATHWAY | 6.83e-04 | 68 | 83 | 4 | MM15930 | |
| Pathway | REACTOME_STAT5_ACTIVATION | 7.06e-04 | 7 | 83 | 2 | M27953 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_JAK_STAT_SIGNALING_PATHWAY | 7.06e-04 | 7 | 83 | 2 | M47581 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GH_JAK_STAT_SIGNALING_PATHWAY | 7.06e-04 | 7 | 83 | 2 | M47646 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_STAT5 | 7.06e-04 | 7 | 83 | 2 | M27907 | |
| Pathway | REACTOME_SIGNALING_BY_CSF3_G_CSF | 7.12e-04 | 30 | 83 | 3 | M41825 | |
| Pathway | WP_KIT_RECEPTOR_SIGNALING_PATHWAY | 8.04e-04 | 71 | 83 | 4 | MM15947 | |
| Pathway | WP_NONSMALL_CELL_LUNG_CANCER | 8.48e-04 | 72 | 83 | 4 | M39738 | |
| Pathway | BIOCARTA_GH_PATHWAY | 9.45e-04 | 33 | 83 | 3 | MM1404 | |
| Pathway | WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS | 1.03e-03 | 34 | 83 | 3 | M48081 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 1.04e-03 | 76 | 83 | 4 | MM15051 | |
| Pathway | REACTOME_NUCLEAR_EVENTS_STIMULATED_BY_ALK_SIGNALING_IN_CANCER | 1.12e-03 | 35 | 83 | 3 | M42525 | |
| Pathway | REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING | 1.12e-03 | 35 | 83 | 3 | MM15144 | |
| Pathway | REACTOME_INTERLEUKIN_7_SIGNALING | 1.22e-03 | 36 | 83 | 3 | M542 | |
| Pathway | PID_GMCSF_PATHWAY | 1.22e-03 | 36 | 83 | 3 | M22 | |
| Pathway | WP_MEASLES_VIRUS_INFECTION | 1.23e-03 | 136 | 83 | 5 | M42547 | |
| Pathway | REACTOME_SIGNALING_BY_SCF_KIT | 1.32e-03 | 37 | 83 | 3 | MM14564 | |
| Pathway | BIOCARTA_EIF2_PATHWAY | 1.49e-03 | 10 | 83 | 2 | MM1469 | |
| Pathway | BIOCARTA_EIF2_PATHWAY | 1.49e-03 | 10 | 83 | 2 | M6924 | |
| Pathway | REACTOME_STAT5_ACTIVATION_DOWNSTREAM_OF_FLT3_ITD_MUTANTS | 1.49e-03 | 10 | 83 | 2 | M41731 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 1.49e-03 | 10 | 83 | 2 | MM15618 | |
| Pathway | REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS | 1.59e-03 | 464 | 83 | 9 | M27547 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 1.64e-03 | 86 | 83 | 4 | M916 | |
| Pathway | WP_IL5_SIGNALING | 1.66e-03 | 40 | 83 | 3 | M39392 | |
| Pathway | KEGG_ERBB_SIGNALING_PATHWAY | 1.72e-03 | 87 | 83 | 4 | M12467 | |
| Pathway | WP_PTF1A_RELATED_REGULATORY_PATHWAY | 1.82e-03 | 11 | 83 | 2 | M39548 | |
| Pathway | WP_IL2_SIGNALING | 1.91e-03 | 42 | 83 | 3 | M39536 | |
| Pathway | WP_HEPATITIS_B_INFECTION | 1.96e-03 | 151 | 83 | 5 | M39801 | |
| Pathway | WP_IL7_SIGNALING_PATHWAY | 2.05e-03 | 43 | 83 | 3 | MM15864 | |
| Pathway | REACTOME_SIGNALING_BY_SCF_KIT | 2.05e-03 | 43 | 83 | 3 | M508 | |
| Pathway | WP_ERBB_SIGNALING | 2.11e-03 | 92 | 83 | 4 | M39715 | |
| Pathway | REACTOME_DEPOLYMERIZATION_OF_THE_NUCLEAR_LAMINA | 2.18e-03 | 12 | 83 | 2 | MM15105 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 2.18e-03 | 12 | 83 | 2 | M27893 | |
| Pathway | BIOCARTA_IL10_PATHWAY | 2.18e-03 | 12 | 83 | 2 | MM1416 | |
| Pathway | REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING | 2.19e-03 | 44 | 83 | 3 | M1012 | |
| Pathway | REACTOME_INTRA_GOLGI_TRAFFIC | 2.19e-03 | 44 | 83 | 3 | M27652 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CYTOKINE_JAK_STAT_SIGNALING_PATHWAY | 2.34e-03 | 45 | 83 | 3 | M47408 | |
| Pathway | WP_PTF1A_RELATED_REGULATORY_PATHWAY | 2.56e-03 | 13 | 83 | 2 | MM15904 | |
| Pathway | BIOCARTA_IL10_PATHWAY | 2.56e-03 | 13 | 83 | 2 | M6778 | |
| Pathway | WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING | 2.65e-03 | 47 | 83 | 3 | M39380 | |
| Pathway | WP_EGFEGFR_SIGNALING | 2.66e-03 | 162 | 83 | 5 | M39334 | |
| Pubmed | PCLO FAM114A2 APOB CHD3 LYST KNOP1 HPCA ATP6V1G3 NRXN3 HPCAL1 CCDC47 SLC25A13 SYNE2 ITSN2 UGGT2 EIF2AK4 ATP2A1 ATP2A2 ATP2A3 PREX1 CUX1 | 6.27e-09 | 1442 | 112 | 21 | 35575683 | |
| Pubmed | A brain-specific homeobox gene, Bsx, is essential for proper postnatal growth and nursing. | 2.11e-08 | 10 | 112 | 4 | 17485440 | |
| Pubmed | Stat5 is indispensable for the maintenance of bcr/abl-positive leukaemia. | 3.25e-08 | 3 | 112 | 3 | 20201032 | |
| Pubmed | 3.25e-08 | 3 | 112 | 3 | 19796718 | ||
| Pubmed | IL-2 and IL-7 induce heterodimerization of STAT5 isoforms in human peripheral blood T lymphoblasts. | 3.25e-08 | 3 | 112 | 3 | 9398404 | |
| Pubmed | 3.25e-08 | 3 | 112 | 3 | 18342552 | ||
| Pubmed | 3.25e-08 | 3 | 112 | 3 | 16410239 | ||
| Pubmed | IL-23 and IL-2 activation of STAT5 is required for optimal IL-22 production in ILC3s during colitis. | 1.30e-07 | 4 | 112 | 3 | 32332067 | |
| Pubmed | 1.30e-07 | 4 | 112 | 3 | 12052827 | ||
| Pubmed | Differential effects of STAT proteins on growth hormone-mediated IGF-I gene expression. | 1.30e-07 | 4 | 112 | 3 | 25205818 | |
| Pubmed | 1.30e-07 | 4 | 112 | 3 | 7719938 | ||
| Pubmed | 1.30e-07 | 4 | 112 | 3 | 25352693 | ||
| Pubmed | Cutting edge: role of STAT1, STAT3, and STAT5 in IFN-alpha beta responses in T lymphocytes. | 1.30e-07 | 4 | 112 | 3 | 15634877 | |
| Pubmed | 1.30e-07 | 4 | 112 | 3 | 25110346 | ||
| Pubmed | 1.30e-07 | 4 | 112 | 3 | 23696567 | ||
| Pubmed | The nongastric H+-K+-ATPases: molecular and functional properties. | 1.30e-07 | 4 | 112 | 3 | 10362770 | |
| Pubmed | 1.30e-07 | 4 | 112 | 3 | 17639043 | ||
| Pubmed | STAT5 outcompetes STAT3 to regulate the expression of the oncogenic transcriptional modulator BCL6. | 1.30e-07 | 4 | 112 | 3 | 23716595 | |
| Pubmed | 1.30e-07 | 4 | 112 | 3 | 28422733 | ||
| Pubmed | DOCK4 MAP2K4 USP9X CYTH2 PCLO GRAMD1A RICTOR MCCC1 HUWE1 RBM39 WDR47 HPCA SUGP2 HPCAL1 MTHFD1 PRKCB ATP2A2 | 1.47e-07 | 1139 | 112 | 17 | 36417873 | |
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 29794014 | ||
| Pubmed | The Current STATus of lymphocyte signaling: new roles for old players. | 3.24e-07 | 5 | 112 | 3 | 19362457 | |
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 23033267 | ||
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 15677474 | ||
| Pubmed | Adaptor proteins NUMB and NUMBL promote cell cycle withdrawal by targeting ERBB2 for degradation. | 3.80e-07 | 19 | 112 | 4 | 28067668 | |
| Pubmed | USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c. | 4.87e-07 | 90 | 112 | 6 | 35654790 | |
| Pubmed | A trimeric Rab7 GEF controls NPC1-dependent lysosomal cholesterol export. | USP9X GRAMD1A MCM4 RICTOR HUWE1 STAT3 STX12 MYOF CCDC47 ATP2A2 | 6.02e-07 | 392 | 112 | 10 | 33144569 |
| Pubmed | N-domain-dependent nonphosphorylated STAT4 dimers required for cytokine-driven activation. | 6.46e-07 | 6 | 112 | 3 | 14704793 | |
| Pubmed | 6.46e-07 | 6 | 112 | 3 | 17082570 | ||
| Pubmed | Nonredundant roles for Stat5a/b in directly regulating Foxp3. | 6.46e-07 | 6 | 112 | 3 | 17227828 | |
| Pubmed | 6.46e-07 | 6 | 112 | 3 | 21278738 | ||
| Pubmed | 6.46e-07 | 6 | 112 | 3 | 27870635 | ||
| Pubmed | 6.46e-07 | 6 | 112 | 3 | 12704203 | ||
| Pubmed | Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. | 6.46e-07 | 6 | 112 | 3 | 17363300 | |
| Pubmed | 6.46e-07 | 6 | 112 | 3 | 10675904 | ||
| Pubmed | 6.46e-07 | 6 | 112 | 3 | 17951529 | ||
| Pubmed | Fatty acid transport protein 2 reprograms neutrophils in cancer. | 6.46e-07 | 6 | 112 | 3 | 30996346 | |
| Pubmed | 1.03e-06 | 24 | 112 | 4 | 30084950 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | DDX47 NR2C1 MCM4 KEAP1 MCCC1 HUWE1 RBM39 STAT3 STAT5A KNOP1 MTHFD1 CCDC47 SLC25A13 PRKCB TOMM40 ATP2A2 EIF2AK2 | 1.11e-06 | 1318 | 112 | 17 | 30463901 |
| Pubmed | Ebf factors and MyoD cooperate to regulate muscle relaxation via Atp2a1. | 1.13e-06 | 7 | 112 | 3 | 24786561 | |
| Pubmed | Transcriptional and physiological roles for STAT proteins in leptin action. | 1.13e-06 | 7 | 112 | 3 | 30718218 | |
| Pubmed | 1.13e-06 | 7 | 112 | 3 | 23797472 | ||
| Pubmed | Signaling through the JAK/STAT pathway, recent advances and future challenges. | 1.13e-06 | 7 | 112 | 3 | 12039028 | |
| Pubmed | Expression and activation of STAT proteins during mouse retina development. | 1.13e-06 | 7 | 112 | 3 | 12634107 | |
| Pubmed | STAT heterodimers in immunity: A mixed message or a unique signal? | 1.13e-06 | 7 | 112 | 3 | 24058793 | |
| Pubmed | Physiological significance of STAT proteins: investigations through gene disruption in vivo. | 1.13e-06 | 7 | 112 | 3 | 10526573 | |
| Pubmed | DDX47 USP9X MCM4 HUWE1 RBM39 SUGP2 MTHFD1 CCDC47 SLC25A13 TOMM40 ATP2A2 | 1.65e-06 | 547 | 112 | 11 | 37267103 | |
| Pubmed | 1.80e-06 | 8 | 112 | 3 | 27879203 | ||
| Pubmed | Functional association of Nmi with Stat5 and Stat1 in IL-2- and IFNgamma-mediated signaling. | 1.80e-06 | 8 | 112 | 3 | 9989503 | |
| Pubmed | 1.80e-06 | 8 | 112 | 3 | 10602027 | ||
| Pubmed | 1.80e-06 | 8 | 112 | 3 | 10951186 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 1.80e-06 | 8 | 112 | 3 | 19033399 | |
| Pubmed | Widespread control of calcium signaling by a family of SERCA-inhibiting micropeptides. | 1.80e-06 | 8 | 112 | 3 | 27923914 | |
| Pubmed | 2.62e-06 | 30 | 112 | 4 | 22056141 | ||
| Pubmed | 2.69e-06 | 9 | 112 | 3 | 10781830 | ||
| Pubmed | A micropeptide encoded by a putative long noncoding RNA regulates muscle performance. | 2.69e-06 | 9 | 112 | 3 | 25640239 | |
| Pubmed | 2.69e-06 | 9 | 112 | 3 | 9484840 | ||
| Pubmed | 2.69e-06 | 9 | 112 | 3 | 31919899 | ||
| Pubmed | 2.69e-06 | 9 | 112 | 3 | 20065083 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DDX47 DNHD1 USP9X PCLO MCM4 APOB HUWE1 CMYA5 RBM39 STX12 MTHFD1 CCDC47 SLC25A13 TOMM40 ATP2A2 EIF2AK2 MGAM2 | 3.18e-06 | 1425 | 112 | 17 | 30948266 |
| Pubmed | USP9X MCM4 RICTOR KEAP1 STAT3 EFR3A SCYL2 MTHFD1 CCDC47 SLC25A13 ATP2A2 NOTCH1 | 3.19e-06 | 708 | 112 | 12 | 39231216 | |
| Pubmed | NR2C1 RBFOX3 USP9X CYTH1 GNPTAB HUWE1 CMYA5 STAT3 ZBED5 STAT5B WDR47 SCYL2 SENP6 ATP2A2 PREX1 CUX1 | 3.72e-06 | 1285 | 112 | 16 | 35914814 | |
| Pubmed | 3.73e-06 | 72 | 112 | 5 | 36376293 | ||
| Pubmed | Structure of the mouse Stat 3/5 locus: evolution from Drosophila to zebrafish to mouse. | 3.84e-06 | 10 | 112 | 3 | 11161808 | |
| Pubmed | 3.84e-06 | 10 | 112 | 3 | 10200816 | ||
| Pubmed | JAK-STAT signaling maintains homeostasis in T cells and macrophages. | 3.84e-06 | 10 | 112 | 3 | 38658806 | |
| Pubmed | 3.84e-06 | 10 | 112 | 3 | 24069548 | ||
| Pubmed | RICTOR RBM39 KNOP1 SUGP2 MTHFD1 CCDC47 SLC25A13 AKAP13 EIF2AK4 ATP2A2 EIF2AK2 | 4.07e-06 | 601 | 112 | 11 | 33658012 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 4.35e-06 | 202 | 112 | 7 | 33005030 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 5.27e-06 | 208 | 112 | 7 | 33230847 | |
| Pubmed | 5.90e-06 | 79 | 112 | 5 | 18978678 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DDX47 MCM4 DGKD RICTOR MCCC1 HUWE1 RBM39 ZBED5 WDR47 SUGP2 MTHFD1 CCDC47 SLC25A13 AKAP13 ATP2A2 EIF2AK2 | 7.13e-06 | 1353 | 112 | 16 | 29467282 |
| Pubmed | 7.98e-06 | 84 | 112 | 5 | 31616248 | ||
| Pubmed | BRPF3 SASH1 KEAP1 INPP5F EFR3A NRXN3 HECW2 SENP6 CDK5RAP2 EIF2AK4 | 8.62e-06 | 529 | 112 | 10 | 14621295 | |
| Pubmed | 8.86e-06 | 418 | 112 | 9 | 34709266 | ||
| Pubmed | 9.08e-06 | 13 | 112 | 3 | 39250533 | ||
| Pubmed | Distribution of the mammalian Stat gene family in mouse chromosomes. | 9.08e-06 | 13 | 112 | 3 | 8530075 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NR2C1 FAM114A2 MCM4 CHD3 KEAP1 MCCC1 RBM39 STAT3 KNOP1 SCYL2 SUGP2 MTHFD1 SENP6 | 1.02e-05 | 934 | 112 | 13 | 33916271 |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 23151802 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 26999798 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 20167868 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 12556521 | ||
| Pubmed | The Status of STAT3 and STAT5 in Human Breast Atypical Ductal Hyperplasia. | 1.03e-05 | 2 | 112 | 2 | 26146825 | |
| Pubmed | A Mouse Model to Assess STAT3 and STAT5A/B Combined Inhibition in Health and Disease Conditions. | 1.03e-05 | 2 | 112 | 2 | 31443474 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 12377952 | ||
| Pubmed | CD36 binds oxidized low density lipoprotein (LDL) in a mechanism dependent upon fatty acid binding. | 1.03e-05 | 2 | 112 | 2 | 25555908 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 15998795 | ||
| Pubmed | A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development. | 1.03e-05 | 2 | 112 | 2 | 21127177 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 16289657 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 25552366 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 25470773 | ||
| Pubmed | STAT3 Impairs STAT5 Activation in the Development of IL-9-Secreting T Cells. | 1.03e-05 | 2 | 112 | 2 | 26976954 | |
| Pubmed | Constitutively active Stat5A and Stat5B promote adipogenesis. | 1.03e-05 | 2 | 112 | 2 | 21431790 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 28500076 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 21826656 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 19644701 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 7720707 | ||
| Pubmed | STAT5A and STAT5B have opposite correlations with drug response gene expression. | 1.03e-05 | 2 | 112 | 2 | 27264955 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 22159083 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 20008792 | ||
| Interaction | ITGB3 interactions | 4.91e-06 | 170 | 112 | 8 | int:ITGB3 | |
| Interaction | EIF3F interactions | HTR2A DDX60 CHD3 HUWE1 RBM39 STAT3 EIF4ENIF1 ZFP36L2 EIF2AK4 NOTCH1 | 6.07e-06 | 296 | 112 | 10 | int:EIF3F |
| Interaction | KCNA3 interactions | DNHD1 USP9X MCM4 RICTOR KEAP1 STAT3 EFR3A SCYL2 MTHFD1 CCDC47 SLC25A13 CTNNA3 SENP6 CDK5RAP2 EIF2AK4 ATP2A2 NOTCH1 | 6.21e-06 | 871 | 112 | 17 | int:KCNA3 |
| Interaction | HDAC1 interactions | NR2C1 MCM4 CHD3 KEAP1 MCCC1 INPP5F KMT2E RBM39 STAT3 STAT5A EIF4ENIF1 ZNF827 CCDC47 SYNE2 CEP135 CDK5RAP2 NOTCH1 CUX1 TPD52L1 | 1.07e-05 | 1108 | 112 | 19 | int:HDAC1 |
| Interaction | ARF6 interactions | HTR2A CYTH2 CYTH1 GRAMD1A DGKD RICTOR STX12 EFR3A CCDC47 SLC25A13 CDK5RAP2 ATP2A1 NOTCH1 | 2.19e-05 | 584 | 112 | 13 | int:ARF6 |
| Interaction | RMC1 interactions | 2.26e-05 | 152 | 112 | 7 | int:RMC1 | |
| Interaction | STAP2 interactions | 3.27e-05 | 33 | 112 | 4 | int:STAP2 | |
| Interaction | PAK6 interactions | 5.39e-05 | 73 | 112 | 5 | int:PAK6 | |
| GeneFamily | ATPases Ca2+ transporting | 6.13e-06 | 9 | 77 | 3 | 1209 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.46e-04 | 206 | 77 | 6 | 682 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.79e-04 | 36 | 77 | 3 | 823 | |
| GeneFamily | EF-hand domain containing | 2.43e-03 | 219 | 77 | 5 | 863 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.80e-03 | 66 | 77 | 3 | 722 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | USP9X CYTH1 GNPTAB GRAMD1A RICTOR CHD3 HUWE1 KMT2E PARP14 LYST RBM39 STAT3 ZBED5 STAT5A STAT5B TBC1D20 EFR3A ZFP36L2 XPO6 ITSN2 SENP6 PRKCB AKAP13 PREX1 NOTCH1 | 3.12e-09 | 1492 | 112 | 25 | M40023 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DOCK4 MAP2K4 SASH1 USP9X CYTH1 INPP5F RBM39 EFR3A MYOF ZFP36L2 HPCAL1 XPO6 SLC25A13 SYNE2 ITSN2 CEP135 AKAP13 CUX1 | 2.38e-08 | 856 | 112 | 18 | M4500 |
| Coexpression | GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_UP | 2.04e-07 | 200 | 112 | 9 | M9030 | |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | DOCK4 AHI1 DDX60 GNPTAB MCM4 CHD3 KNOP1 EFR3A MYOF ZFP36L2 SLC25A13 SYNE2 UGGT2 AKAP13 ATP2A2 CUX1 | 2.56e-07 | 790 | 112 | 16 | M12490 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | NR2C1 CYTH2 CYTH1 GRAMD1A MPEG1 CLCN6 SUGP2 ZFP36L2 ZNF827 XPO6 AKAP13 ATP2A2 NOTCH1 CUX1 | 5.53e-07 | 634 | 112 | 14 | M40866 |
| Coexpression | GSE40277_GATA1_AND_SATB1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN | 2.32e-06 | 199 | 112 | 8 | M9178 | |
| Coexpression | GSE40666_WT_VS_STAT1_KO_CD8_TCELL_UP | 2.41e-06 | 200 | 112 | 8 | M9205 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | NR2C1 CYTH2 CYTH1 GRAMD1A MPEG1 MYOF CLCN6 SUGP2 ZFP36L2 ZNF827 XPO6 AKAP13 ATP2A2 NOTCH1 CUX1 | 7.30e-06 | 905 | 112 | 15 | M40865 |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | DDX47 DOCK4 MAP2K4 FRAS1 DDX60 LAMA4 MCM4 FAM200A FANCM KNOP1 SCYL2 CDCA7 SLC25A13 CEP135 SENP6 TOMM40 EIF2AK4 ANAPC5 EIF2AK2 | 7.74e-06 | 1407 | 112 | 19 | M14427 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | DOCK4 PSD2 RBFOX3 CYTH1 PCLO GNPTAB FAM114A2 RICTOR CHD3 KMT2E LYST NRXN3 SUGP2 PRKCB HS6ST3 TPD52L1 | 1.91e-05 | 1106 | 112 | 16 | M39071 |
| Coexpression | GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_DN | 2.34e-05 | 198 | 112 | 7 | M3242 | |
| Coexpression | GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_DN | 2.42e-05 | 199 | 112 | 7 | M9418 | |
| Coexpression | GSE26669_CD4_VS_CD8_TCELL_IN_MLR_COSTIM_BLOCK_DN | 2.42e-05 | 199 | 112 | 7 | M4673 | |
| Coexpression | GSE24142_DN2_VS_DN3_THYMOCYTE_ADULT_DN | 2.42e-05 | 199 | 112 | 7 | M4567 | |
| Coexpression | GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_UP | 2.50e-05 | 200 | 112 | 7 | M3035 | |
| Coexpression | MURARO_PANCREAS_ENDOTHELIAL_CELL | 2.61e-05 | 362 | 112 | 9 | M39176 | |
| Coexpression | BUSSLINGER_DUODENAL_IMMUNE_CELLS | GNPTAB GRAMD1A CHD3 KMT2E RBM39 STAT3 ZFP36L2 XPO6 SYNE2 ITSN2 PRKCB AKAP13 ATP2A3 PREX1 | 3.46e-05 | 911 | 112 | 14 | M40038 |
| Coexpression | PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7 | 5.54e-05 | 399 | 112 | 9 | M2413 | |
| Coexpression | CHICAS_RB1_TARGETS_LOW_SERUM | 8.17e-05 | 103 | 112 | 5 | M2126 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN | 8.47e-05 | 54 | 112 | 4 | M5312 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN | 1.05e-04 | 57 | 112 | 4 | MM463 | |
| Coexpression | GALE_APL_WITH_FLT3_MUTATED_UP | 1.20e-04 | 59 | 112 | 4 | M3845 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_CD5_POS_CCL22_POS_MATURE_B_CELL | GNPTAB MPEG1 CHD3 HUWE1 KNOP1 SCYL2 ZNF827 CCDC47 SLC25A13 SYNE2 ATP2A2 | 1.35e-04 | 666 | 112 | 11 | M45778 |
| Coexpression | GSE9960_HEALTHY_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP | 1.56e-04 | 187 | 112 | 6 | M7123 | |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP | 2.01e-04 | 196 | 112 | 6 | M5381 | |
| Coexpression | GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_10DY_UP | 2.01e-04 | 196 | 112 | 6 | M41141 | |
| Coexpression | GSE22033_UNTREATED_VS_MRL24_TREATED_MEF_DN | 2.06e-04 | 197 | 112 | 6 | M7696 | |
| Coexpression | GSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_UP | 2.06e-04 | 197 | 112 | 6 | M3307 | |
| Coexpression | GSE2706_UNSTIM_VS_8H_LPS_DC_DN | 2.12e-04 | 198 | 112 | 6 | M4701 | |
| Coexpression | GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_DN | 2.18e-04 | 199 | 112 | 6 | M3286 | |
| Coexpression | GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_DN | 2.18e-04 | 199 | 112 | 6 | M4571 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 2.18e-04 | 199 | 112 | 6 | M5893 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_6_7WK_UP | 2.18e-04 | 199 | 112 | 6 | MM991 | |
| Coexpression | GSE26156_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP | 2.18e-04 | 199 | 112 | 6 | M8298 | |
| Coexpression | GSE23505_UNTREATED_VS_4DAY_IL6_IL1_IL23_TREATED_CD4_TCELL_DN | 2.18e-04 | 199 | 112 | 6 | M7853 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_6_7WK_UP | 2.18e-04 | 199 | 112 | 6 | M2155 | |
| Coexpression | GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | 2.24e-04 | 200 | 112 | 6 | M291 | |
| Coexpression | GSE411_100MIN_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN | 2.24e-04 | 200 | 112 | 6 | M5995 | |
| Coexpression | GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY7_DN | 2.24e-04 | 200 | 112 | 6 | M9370 | |
| Coexpression | GSE9650_NAIVE_VS_EXHAUSTED_CD8_TCELL_DN | 2.24e-04 | 200 | 112 | 6 | M5828 | |
| Coexpression | GSE9650_EFFECTOR_VS_MEMORY_CD8_TCELL_DN | 2.24e-04 | 200 | 112 | 6 | M5837 | |
| Coexpression | GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_DN | 2.24e-04 | 200 | 112 | 6 | M8306 | |
| Coexpression | GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_UP | 2.24e-04 | 200 | 112 | 6 | M8564 | |
| Coexpression | GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY3_DN | 2.24e-04 | 200 | 112 | 6 | M8486 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_12H_BMDC_DN | 2.24e-04 | 200 | 112 | 6 | M3975 | |
| Coexpression | GSE39820_CTRL_VS_TGFBETA3_IL6_CD4_TCELL_DN | 2.24e-04 | 200 | 112 | 6 | M5612 | |
| Coexpression | LEE_DIFFERENTIATING_T_LYMPHOCYTE | 2.30e-04 | 201 | 112 | 6 | M2200 | |
| Coexpression | STK33_UP | 2.34e-04 | 286 | 112 | 7 | M2858 | |
| Coexpression | HU_FETAL_RETINA_MICROGLIA | 2.41e-04 | 382 | 112 | 8 | M39266 | |
| Coexpression | GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_7DY_UP | 2.65e-04 | 292 | 112 | 7 | M41140 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_DN | 2.71e-04 | 133 | 112 | 5 | M8880 | |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_DN | DDX47 NR2C1 MAP2K4 HTR2A USP9X PCLO MCM4 MCCC1 HPCA MTHFD1 ITSN2 PRKCB UGGT2 ATP2A2 TPD52L1 | 2.77e-04 | 1248 | 112 | 15 | M17728 |
| Coexpression | AIZARANI_LIVER_C34_MHC_II_POS_B_CELLS | 2.81e-04 | 134 | 112 | 5 | M39133 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_DN | 3.11e-04 | 137 | 112 | 5 | MM990 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN | 3.19e-04 | 504 | 112 | 9 | M2157 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 3.82e-04 | 221 | 112 | 6 | M39222 | |
| Coexpression | YAGI_AML_WITH_INV_16_TRANSLOCATION | 3.93e-04 | 411 | 112 | 8 | M1047 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500 | 1.04e-07 | 201 | 111 | 10 | gudmap_developingKidney_e15.5_500_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_500 | AHI1 USP9X LAMA4 DGKD CHST9 HUWE1 GPC6 TFAP2B KNOP1 AKAP13 EIF2AK2 CUX1 | 1.31e-06 | 402 | 111 | 12 | gudmap_developingKidney_e15.5_anlage of loop of Henle_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.36e-06 | 152 | 111 | 8 | gudmap_developingKidney_e15.5_S-shaped body_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | AHI1 USP9X DGKD CHST9 HUWE1 GPC6 TFAP2B RBM39 KNOP1 EIF2AK2 CUX1 | 4.40e-06 | 375 | 111 | 11 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | MAP2K4 AHI1 RBFOX3 USP9X PCLO GNPTAB HUWE1 WDR47 SCYL2 HPCA TRAPPC6B SYNE2 CEP135 CCDC171 ANAPC5 CUX1 | 6.61e-06 | 831 | 111 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29965_k-means-cluster#3_top-relative-expression-ranked_200 | 7.64e-06 | 8 | 111 | 3 | gudmap_developingKidney_e15.5_Endothelial cells_200_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.18e-05 | 146 | 111 | 7 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.51e-05 | 226 | 111 | 8 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | USP9X DGKD CHST9 HUWE1 GPC6 TFAP2B KNOP1 AKAP13 EIF2AK2 CUX1 | 3.03e-05 | 379 | 111 | 10 | gudmap_developingKidney_e15.5_1000_k3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#3_top-relative-expression-ranked_500 | 4.31e-05 | 74 | 111 | 5 | gudmap_developingKidney_e15.5_S-shaped body_500_k3 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | DOCK4 USP9X DDX60 CHD3 TEX15 MCCC1 SCYL2 ZFP36L2 HPCAL1 HECW2 CD36 CTNNA3 CCDC171 EIF2AK2 | 6.54e-05 | 791 | 111 | 14 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | GPLD1 AHI1 USP9X LAMA4 HUWE1 GPC6 STAT5A STAT5B KNOP1 EFR3A ZNF827 AKAP13 EIF2AK2 CUX1 | 7.98e-05 | 806 | 111 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#2_top-relative-expression-ranked_200 | 9.89e-05 | 88 | 111 | 5 | gudmap_developingKidney_e15.5_200_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#4_top-relative-expression-ranked_200 | 1.46e-04 | 51 | 111 | 4 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_200_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_200 | 1.65e-04 | 155 | 111 | 6 | gudmap_developingKidney_e15.5_anlage of loop of Henle_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.82e-04 | 225 | 111 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29965_top-relative-expression-ranked_500 | 1.88e-04 | 384 | 111 | 9 | gudmap_developingKidney_e15.5_Endothelial cells_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_top-relative-expression-ranked_500 | 1.88e-04 | 384 | 111 | 9 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#1_top-relative-expression-ranked_200 | 1.99e-04 | 22 | 111 | 3 | gudmap_developingKidney_e15.5_Cap mesenchyme_200_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_500 | 2.17e-04 | 163 | 111 | 6 | gudmap_developingKidney_e15.5_cortic collect duct_500_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | MAP2K4 RBFOX3 USP9X GNPTAB HUWE1 SCYL2 EIF4ENIF1 TRAPPC6B SYNE2 ITSN2 UGGT2 ANAPC5 CUX1 | 2.19e-04 | 780 | 111 | 13 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.37e-04 | 312 | 111 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | DOCK4 USP9X TEX15 MCCC1 KNOP1 SCYL2 TENM3 ZFP36L2 HPCAL1 CD36 ITSN2 CCDC171 EIF2AK2 | 2.90e-04 | 803 | 111 | 13 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#3_top-relative-expression-ranked_500 | 3.61e-04 | 116 | 111 | 5 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_500 | 3.69e-04 | 421 | 111 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.12e-04 | 339 | 111 | 8 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_top-relative-expression-ranked_1000 | DOCK4 BRPF3 USP9X LAMA4 TEX15 SCYL2 ZFP36L2 ZNF827 HPCAL1 HECW2 CTNNA3 PRKCB TPD52L1 | 4.30e-04 | 837 | 111 | 13 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.48e-04 | 261 | 111 | 7 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#5_top-relative-expression-ranked_200 | 4.71e-04 | 69 | 111 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#5_top-relative-expression-ranked_200 | 4.71e-04 | 69 | 111 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_J_200_k5 | |
| CoexpressionAtlas | gudmap_RNAseq_p2_Glomerlular Endothelial_2500_K1 | DOCK4 SASH1 CYTH1 DUSP8 STAT3 STX12 SLC46A3 HPCAL1 TRAPPC6B ITSN2 AKAP13 PREX1 NOTCH1 | 4.97e-04 | 850 | 111 | 13 | gudmap_RNAseq_p2_Glomerlular Endothelial_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | 5.51e-04 | 194 | 111 | 6 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.09e-09 | 200 | 112 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 2.09e-09 | 200 | 112 | 9 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 3.22e-08 | 193 | 112 | 8 | 7256a5a491536c525b31ae96d47ab5c6303cb73a | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 4.98e-07 | 188 | 112 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-07 | 188 | 112 | 7 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-07 | 192 | 112 | 7 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.29e-07 | 199 | 112 | 7 | 32bdfff40fd442b88489c8b0f79af3927a51a03c | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.29e-07 | 199 | 112 | 7 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.29e-07 | 199 | 112 | 7 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.79e-06 | 156 | 112 | 6 | f5889a6899904dfb7f596600b3a76857cf9d5378 | |
| ToppCell | P28-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.27e-06 | 168 | 112 | 6 | 8c8dbdbc7053f34e4ca0c5067af502fbea109fc1 | |
| ToppCell | IIH-CD8-naive_CD4|IIH / Condition, Cell_class and T cell subcluster | 5.06e-06 | 173 | 112 | 6 | 4f2843371d18af766c1892529ce286f56c956fde | |
| ToppCell | CF-Myeloid-Neutrophil|Myeloid / Disease state, Lineage and Cell class | 5.40e-06 | 175 | 112 | 6 | 8020c3a34f77e68e8149f87481fb1dddd2ac675e | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-06 | 178 | 112 | 6 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | droplet-Kidney-nan-3m-Hematologic-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.56e-06 | 181 | 112 | 6 | 58d7e76dfaa818aeaef7f129c4472bf5b6563218 | |
| ToppCell | droplet-Kidney-nan-3m-Hematologic|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.56e-06 | 181 | 112 | 6 | 5d76e99bf2b5b337041efd3cd33bebbb0637b64e | |
| ToppCell | droplet-Kidney-nan-3m-Hematologic-leukocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.56e-06 | 181 | 112 | 6 | 970fc90e27236ee30190f1a02f418a378919c60b | |
| ToppCell | CF-Myeloid-Neutrophil|CF / Disease state, Lineage and Cell class | 6.98e-06 | 183 | 112 | 6 | da43827952e6fdee2ce94648c316182f272b321c | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.20e-06 | 184 | 112 | 6 | e2de27cee3ea80f9b7a9a7884ceceeaa67b3214a | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 7.20e-06 | 184 | 112 | 6 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | COVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 7.43e-06 | 185 | 112 | 6 | 4a095829992b39856a73bdfac03ee68b9aa0d3b8 | |
| ToppCell | COVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 7.43e-06 | 185 | 112 | 6 | 36ce23893915f5c380cca39b2c33a516edf31c3a | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 8.39e-06 | 189 | 112 | 6 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.39e-06 | 189 | 112 | 6 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.39e-06 | 189 | 112 | 6 | 222e67d3fd106c43b0cae6538dddeaa7be1f759f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.65e-06 | 190 | 112 | 6 | 59720dfe9de1b980807644536c919d2a02ba69dd | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.65e-06 | 190 | 112 | 6 | 625c08a0e5227efc46daa512fd579c3938ff76c7 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.18e-06 | 192 | 112 | 6 | b7c01e12b3e9be960a741b08835f1dfff65d0d47 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 9.46e-06 | 193 | 112 | 6 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | facs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.74e-06 | 194 | 112 | 6 | f1661f9f2439fca5c1012c693b0744c4e3b90a9b | |
| ToppCell | facs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.74e-06 | 194 | 112 | 6 | cda1b197efb199330ea7ab25a7cee22cae22589d | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 9.74e-06 | 194 | 112 | 6 | 8dcde77767b23e75360adb316cdccf56a00e3726 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.74e-06 | 194 | 112 | 6 | 66c056232ac216780acf4cc8ea325bd8ed1909c9 | |
| ToppCell | PCW_07-8.5-Epithelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.74e-06 | 194 | 112 | 6 | f63ceedb88a9abc8644ee94adfd541e7817c1e3a | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-05 | 195 | 112 | 6 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-05 | 195 | 112 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | facs-Lung-nan-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-05 | 195 | 112 | 6 | 7f9b7f15006610ad591063d90e90367bd6083c7f | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-05 | 195 | 112 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.06e-05 | 197 | 112 | 6 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-05 | 197 | 112 | 6 | 10190b877bf46ba2163d203df9dd3b498c66e52f | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.06e-05 | 197 | 112 | 6 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.09e-05 | 198 | 112 | 6 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.09e-05 | 198 | 112 | 6 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 1.09e-05 | 198 | 112 | 6 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.09e-05 | 198 | 112 | 6 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.13e-05 | 199 | 112 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | control-CD163+_Monocytes_(Sample_ID1_d7)|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.13e-05 | 199 | 112 | 6 | 933201d32eda12a89660bdbae9114a95cc428a38 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.13e-05 | 199 | 112 | 6 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.16e-05 | 200 | 112 | 6 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.16e-05 | 200 | 112 | 6 | e90155498397524b812c46f2412320230b445bb6 | |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.16e-05 | 200 | 112 | 6 | 109f673a4967ffa52270a0b4f818b3461288db44 | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 1.16e-05 | 200 | 112 | 6 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.16e-05 | 200 | 112 | 6 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-cortical_neurons_2|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.16e-05 | 200 | 112 | 6 | 0cb0755a101ec655359d051d6a8807408d727c55 | |
| ToppCell | COVID_non-vent|World / Disease condition, Lineage, Cell class and subclass | 1.16e-05 | 200 | 112 | 6 | accef1050963dc91e189ac3d38228f15bf57e06e | |
| ToppCell | LV-03._Atrial_Cardiomyocyte|LV / Chamber and Cluster_Paper | 1.33e-05 | 120 | 112 | 5 | 3b77bd0e3630cdd45001cecf5e47660a90ebc92e | |
| ToppCell | droplet-Liver-nan-3m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 127 | 112 | 5 | 39fa20a55de3af1a62ab5dfa4877879db3935ac2 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 4.00e-05 | 151 | 112 | 5 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.27e-05 | 160 | 112 | 5 | 14dfa519e68bab4bce890ddb66fa7763f18d9f19 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.27e-05 | 160 | 112 | 5 | 839bbdfd4e4c7b48260c8bfb7670378634405e1d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.27e-05 | 160 | 112 | 5 | 5b7789d4668ed7732babedc32d812233b430e0bd | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.27e-05 | 160 | 112 | 5 | bba1486faaad5299e10f4fe17c6d149c28dc2560 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related-Tuft|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.43e-05 | 161 | 112 | 5 | f5df8c6a340d5026726804b103e32137f363ca40 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.59e-05 | 162 | 112 | 5 | d28b2ea1d2c8f3c6a107991573471b6d0c49c4ae | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.59e-05 | 162 | 112 | 5 | 5bbd7130d4dad9035e73a439dda568195c136f31 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.59e-05 | 162 | 112 | 5 | eed223e61c8162a2fe004ab4e09de5e037be7553 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.59e-05 | 162 | 112 | 5 | e35ddce830e20ebeac1a2c405293fc4a5323dd4a | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.93e-05 | 164 | 112 | 5 | f9a2cc12179d5621c9174ec01d7418a71edd28d1 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related-Tuft|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.10e-05 | 165 | 112 | 5 | 34fd00be2b28716c871ad9fb356de84a299a0c01 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.03e-05 | 170 | 112 | 5 | 90f7640f04672c800cb28aea50004b1bb0565e8a | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.23e-05 | 171 | 112 | 5 | a31c23406cf6d6a17358a8fb41d392a7fb0306e0 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.23e-05 | 171 | 112 | 5 | 43d8fd9b9546e84a652564fe96b514b34b06262b | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-DN4|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.23e-05 | 171 | 112 | 5 | f08402d0f42822c35673522043b652f8fb68d2f6 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D231|Adult / Lineage, Cell type, age group and donor | 7.84e-05 | 174 | 112 | 5 | 7d2f802f493f19a068e097b2909a9000e2160266 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.28e-05 | 176 | 112 | 5 | 269326c2bf44a9003d95bc6dbc839f08f25737ca | |
| ToppCell | Control-Neuronal_cells-Neuronal_cells|Control / group, cell type (main and fine annotations) | 8.28e-05 | 176 | 112 | 5 | 98c07d26ba0dc0fe15ca0ea81f633d4591782bd1 | |
| ToppCell | Control-Neuronal_cells|Control / group, cell type (main and fine annotations) | 8.28e-05 | 176 | 112 | 5 | c29d09ecf0eb17f767d78af4b7f2e7725c967ff8 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 8.28e-05 | 176 | 112 | 5 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | ILEUM-inflamed-(9)_Enteric_neurons|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.73e-05 | 178 | 112 | 5 | d9142151819afb0dc22bfb32a9c9dba5f553067d | |
| ToppCell | IIF-Lymphocyte-T_NK-MAIT|IIF / Disease, Lineage and Cell Type | 8.73e-05 | 178 | 112 | 5 | be777ebef8f09a1a16fcee8fc69a65ab295b6e1d | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231|Adult / Lineage, Cell type, age group and donor | 8.73e-05 | 178 | 112 | 5 | c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815 | |
| ToppCell | ILEUM-inflamed-(9)_Neuro_cell|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.73e-05 | 178 | 112 | 5 | 611504b0a9e6318b18fba83787b03f9245c82252 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.73e-05 | 178 | 112 | 5 | 674ee5095b98929c29e4f6bd56029a336cc4a38c | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.96e-05 | 179 | 112 | 5 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.20e-05 | 180 | 112 | 5 | 5391d23817f5cc88a0871ddb98968897c839f464 | |
| ToppCell | 5'-Adult-Appendix-Neuronal-Glial_mature|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.44e-05 | 181 | 112 | 5 | 3aa81ac64d0cc9a74fbfa71e2176740548e7cd06 | |
| ToppCell | 5'-Adult-Appendix-Neuronal-Glial_mature-Adult_Glia|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.44e-05 | 181 | 112 | 5 | 997ba1be2824b00d684f2163d0114656ed11fa53 | |
| ToppCell | Monocytes-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 9.44e-05 | 181 | 112 | 5 | d8b98c3d9bef026a0a35948219027f27718ffbee | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.44e-05 | 181 | 112 | 5 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.44e-05 | 181 | 112 | 5 | e898ecb8d8f2eb2204225b7b0d665cadcd241139 | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 9.44e-05 | 181 | 112 | 5 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | 5'-Adult-Appendix-Neuronal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.44e-05 | 181 | 112 | 5 | e6b7e8dd5c13cc10ba22f2f5a8c669486f934bdc | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.44e-05 | 181 | 112 | 5 | fad7ba168f541ac9d04edebc206f191e48bb7e99 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.69e-05 | 182 | 112 | 5 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.69e-05 | 182 | 112 | 5 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.94e-05 | 183 | 112 | 5 | ba43bca2b45be1008eebd3f033cecb061fb3a966 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.94e-05 | 183 | 112 | 5 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 9.94e-05 | 183 | 112 | 5 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.94e-05 | 183 | 112 | 5 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 184 | 112 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| Drug | AZD 1480 | 4.50e-07 | 4 | 111 | 3 | ctd:C545606 | |
| Drug | Dacarbazine [4342-03-4]; Down 200; 22uM; PC3; HT_HG-U133A | 5.82e-07 | 199 | 111 | 9 | 4480_DN | |
| Drug | Les T | 2.41e-06 | 123 | 111 | 7 | CID000003189 | |
| Drug | magnesium fluoride | 5.99e-06 | 53 | 111 | 5 | CID000024546 | |
| Drug | Thapsigargin | DNHD1 MAP2K4 USP9X MCM4 KEAP1 TFAP2B RBM39 STAT3 EFR3A HPCA MYOF CDCA7 MTHFD1 SLC25A13 CDK5RAP2 PRKCB CCDC171 ATP2A1 ATP2A2 ATP2A3 | 7.83e-06 | 1353 | 111 | 20 | ctd:D019284 |
| Drug | ATP-EDC | 1.32e-05 | 10 | 111 | 3 | CID000195647 | |
| Drug | 2,4-dihydroxy-N-(4-hydroxyphenyl)benzamide | 1.32e-05 | 10 | 111 | 3 | ctd:C585912 | |
| Drug | 1sqc | 1.32e-05 | 10 | 111 | 3 | CID000444279 | |
| Drug | 2,5-dimethylquinone | 1.81e-05 | 11 | 111 | 3 | CID000008718 | |
| Drug | strontium | 2.05e-05 | 68 | 111 | 5 | CID000104798 | |
| Drug | 1vyq | 2.40e-05 | 12 | 111 | 3 | CID004369390 | |
| Drug | AC1NST48 | GPLD1 TSGA13 CYTH2 CYTH1 KERA DGKD APOB GPC6 LYST STX12 SCYL2 ZFP36L2 | 3.35e-05 | 594 | 111 | 12 | CID005315496 |
| Drug | p-hydroxyhippuric acid | 3.95e-05 | 14 | 111 | 3 | CID000151012 | |
| Drug | myo-inositol | GPLD1 MAP2K4 PSD2 HTR2A CYTH1 DGKD RICTOR INPP5F PRKCB ATP2A1 ATP2A2 ATP2A3 PREX1 CUX1 | 4.05e-05 | 811 | 111 | 14 | CID000000892 |
| Drug | carbidine | 4.27e-05 | 40 | 111 | 4 | CID000065684 | |
| Drug | Haloperidol [52-86-8]; Down 200; 10.6uM; PC3; HT_HG-U133A | 4.71e-05 | 194 | 111 | 7 | 4678_DN | |
| Drug | NSC239129 | 4.92e-05 | 15 | 111 | 3 | CID000084597 | |
| Drug | Naloxone hydrochloride [357-08-4]; Up 200; 11uM; MCF7; HT_HG-U133A | 5.02e-05 | 196 | 111 | 7 | 5606_UP | |
| Drug | Diethylstilbestrol [56-53-1]; Up 200; 15uM; PC3; HT_HG-U133A | 5.02e-05 | 196 | 111 | 7 | 4547_UP | |
| Drug | Oxybutynin chloride [1508-65-2]; Down 200; 10.2uM; HL60; HG-U133A | 5.19e-05 | 197 | 111 | 7 | 1551_DN | |
| Drug | Ethotoin [86-35-1]; Up 200; 19.6uM; PC3; HT_HG-U133A | 5.19e-05 | 197 | 111 | 7 | 4545_UP | |
| Drug | C12E8 | 5.19e-05 | 42 | 111 | 4 | CID000123921 | |
| Drug | Nomegestrol acetate [58652-20-3]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 5.36e-05 | 198 | 111 | 7 | 6525_DN | |
| Drug | Methantheline bromide [53-46-3]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 5.36e-05 | 198 | 111 | 7 | 6254_UP | |
| Drug | Epirizole [18694-40-1]; Up 200; 17uM; MCF7; HT_HG-U133A | 5.53e-05 | 199 | 111 | 7 | 5995_UP | |
| Drug | AC1L88YH | 7.30e-05 | 17 | 111 | 3 | CID000374551 | |
| Drug | agelasine B | 7.46e-05 | 46 | 111 | 4 | CID006439899 | |
| Drug | benzo(a)pyrene-3,6-quinone | 8.72e-05 | 18 | 111 | 3 | ctd:C018003 | |
| Disease | Brody myopathy (implicated_via_orthology) | 5.04e-08 | 3 | 110 | 3 | DOID:0050692 (implicated_via_orthology) | |
| Disease | T-Cell Large Granular Lymphocyte Leukemia | 1.38e-05 | 2 | 110 | 2 | C1955861 | |
| Disease | gallbladder cancer (is_implicated_in) | 1.40e-05 | 13 | 110 | 3 | DOID:3121 (is_implicated_in) | |
| Disease | silicosis (implicated_via_orthology) | 8.22e-05 | 4 | 110 | 2 | DOID:10325 (implicated_via_orthology) | |
| Disease | urolithiasis | 9.19e-05 | 63 | 110 | 4 | MONDO_0024647 | |
| Disease | colon adenocarcinoma (is_implicated_in) | 1.23e-04 | 26 | 110 | 3 | DOID:234 (is_implicated_in) | |
| Disease | Leukemia, T-Cell | 1.37e-04 | 5 | 110 | 2 | C0023492 | |
| Disease | colorectal adenocarcinoma (is_marker_for) | 1.38e-04 | 27 | 110 | 3 | DOID:0050861 (is_marker_for) | |
| Disease | gastric adenocarcinoma (is_marker_for) | 1.54e-04 | 28 | 110 | 3 | DOID:3717 (is_marker_for) | |
| Disease | waist circumference | 2.10e-04 | 429 | 110 | 8 | EFO_0004342 | |
| Disease | pulmonary venoocclusive disease (biomarker_via_orthology) | 2.86e-04 | 7 | 110 | 2 | DOID:5453 (biomarker_via_orthology) | |
| Disease | Major Depressive Disorder | 3.08e-04 | 243 | 110 | 6 | C1269683 | |
| Disease | heart disease (implicated_via_orthology) | 3.87e-04 | 38 | 110 | 3 | DOID:114 (implicated_via_orthology) | |
| Disease | Unipolar Depression | 4.31e-04 | 259 | 110 | 6 | C0041696 | |
| Disease | Autistic Disorder | 4.49e-04 | 261 | 110 | 6 | C0004352 | |
| Disease | obsolete_red blood cell distribution width | AHI1 CYTH1 FAM114A2 APOB CLCN6 CDCA7 HECW2 CD36 SYNE2 AKAP13 EIF2AK4 GALNT6 EIF2AK2 NOTCH1 | 4.88e-04 | 1347 | 110 | 14 | EFO_0005192 |
| Disease | Prostatic Neoplasms | 5.08e-04 | 616 | 110 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 5.08e-04 | 616 | 110 | 9 | C0376358 | |
| Disease | reticulocyte measurement | USP9X GRAMD1A RICTOR ATP6V1G3 ZFP36L2 ZNF827 SYNE2 AKAP13 EIF2AK4 EIF2AK2 PREX1 CUX1 | 5.68e-04 | 1053 | 110 | 12 | EFO_0010700 |
| Disease | Malignant neoplasm of breast | MAP2K4 KEAP1 STAT3 STAT5A STX12 OTOGL SYNE2 ITSN2 ATP2A3 ANAPC5 NOTCH1 CUX1 | 6.75e-04 | 1074 | 110 | 12 | C0006142 |
| Disease | waist-hip ratio, body mass index | 8.87e-04 | 12 | 110 | 2 | EFO_0004340, EFO_0004343 | |
| Disease | lymphangioleiomyomatosis (is_marker_for) | 8.87e-04 | 12 | 110 | 2 | DOID:3319 (is_marker_for) | |
| Disease | Polydactyly | 9.81e-04 | 117 | 110 | 4 | C0152427 | |
| Disease | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1.03e-03 | 53 | 110 | 3 | C1961099 | |
| Disease | systolic blood pressure, cigarettes per day measurement | 1.05e-03 | 13 | 110 | 2 | EFO_0006335, EFO_0006525 | |
| Disease | middle temporal gyrus volume measurement, Alzheimer's disease biomarker measurement | 1.05e-03 | 13 | 110 | 2 | EFO_0006514, EFO_0010316 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 1.37e-03 | 128 | 110 | 4 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 1.37e-03 | 128 | 110 | 4 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 1.37e-03 | 128 | 110 | 4 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 1.37e-03 | 128 | 110 | 4 | C1306837 | |
| Disease | Renal Cell Carcinoma | 1.37e-03 | 128 | 110 | 4 | C0007134 | |
| Disease | Autosomal recessive primary microcephaly | 1.40e-03 | 15 | 110 | 2 | cv:C3711387 | |
| Disease | alkaline phosphatase measurement | GPLD1 MAP2K4 TCP11 APOB CHD3 ZNF827 XPO6 CD36 AKAP13 TOMM40 NOTCH1 | 1.45e-03 | 1015 | 110 | 11 | EFO_0004533 |
| Disease | Diabetes Mellitus, Non-Insulin-Dependent | 1.46e-03 | 221 | 110 | 5 | C0011860 | |
| Disease | Global developmental delay | 1.57e-03 | 133 | 110 | 4 | C0557874 | |
| Disease | Schizoaffective disorder-bipolar type | 1.60e-03 | 16 | 110 | 2 | EFO_0009965 | |
| Disease | T-Cell Lymphoma | 1.60e-03 | 16 | 110 | 2 | C0079772 | |
| Disease | heart disease (biomarker_via_orthology) | 1.81e-03 | 17 | 110 | 2 | DOID:114 (biomarker_via_orthology) | |
| Disease | hyperglycemia (implicated_via_orthology) | 1.81e-03 | 17 | 110 | 2 | DOID:4195 (implicated_via_orthology) | |
| Disease | facial height measurement | 2.00e-03 | 142 | 110 | 4 | EFO_0007856 | |
| Disease | asthma | MAP2K4 AHI1 TCP11 STAT5B ATP6V1G3 CDCA7 ITSN2 CTNNA3 CDK5RAP2 | 2.02e-03 | 751 | 110 | 9 | MONDO_0004979 |
| Disease | glucose homeostasis measurement, acute insulin response measurement | 2.03e-03 | 18 | 110 | 2 | EFO_0006831, EFO_0006896 | |
| Disease | waist-hip ratio | LAMA4 SCEL GPC6 TFAP2B STAT5B NRXN3 SYNE2 TOMM40 CCDC171 ATP2A1 CUX1 PROX1 | 2.08e-03 | 1226 | 110 | 12 | EFO_0004343 |
| Disease | dehydroepiandrosterone sulphate measurement | 2.12e-03 | 68 | 110 | 3 | EFO_0007001 | |
| Disease | obesity | 2.13e-03 | 241 | 110 | 5 | EFO_0001073 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 2.32e-03 | 148 | 110 | 4 | C0279702 | |
| Disease | atherosclerosis (biomarker_via_orthology) | 2.50e-03 | 20 | 110 | 2 | DOID:1936 (biomarker_via_orthology) | |
| Disease | osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty | 2.76e-03 | 21 | 110 | 2 | EFO_0004616, EFO_0010726, EFO_1000786 | |
| Disease | body surface area | 2.85e-03 | 643 | 110 | 8 | EFO_0022196 | |
| Disease | blood pressure | 3.03e-03 | 22 | 110 | 2 | EFO_0004325 | |
| Disease | Splenomegaly | 3.03e-03 | 22 | 110 | 2 | C0038002 | |
| Disease | Autosomal Recessive Primary Microcephaly | 3.03e-03 | 22 | 110 | 2 | C3711387 | |
| Disease | Primary microcephaly | 3.03e-03 | 22 | 110 | 2 | C0431350 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 3.51e-03 | 166 | 110 | 4 | EFO_0004530, EFO_0004611 | |
| Disease | Coronary heart disease | 3.60e-03 | 24 | 110 | 2 | C0010068 | |
| Disease | Dyslipidemias | 3.60e-03 | 24 | 110 | 2 | C0242339 | |
| Disease | Dyslipoproteinemias | 3.60e-03 | 24 | 110 | 2 | C0598784 | |
| Disease | Cardiomegaly | 3.60e-03 | 82 | 110 | 3 | C0018800 | |
| Disease | Cardiac Hypertrophy | 3.60e-03 | 82 | 110 | 3 | C1383860 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RLKQSKIMGSQNNLS | 56 | Q96LB4 | |
| QMSQSKRLGSLNKFK | 296 | Q9H0S4 | |
| ILKGNFSIRTAKMQQ | 1051 | Q9P2K8 | |
| NKNKSQDFRLGSESM | 1146 | Q8N157 | |
| GKFALNSLLQRQLMQ | 476 | P39880 | |
| GSQKDVLNKDLMTQN | 171 | Q13202 | |
| LDKAQGLQMQLNEFK | 1011 | Q6TFL3 | |
| GLQMQLNEFKQSKLI | 1016 | Q6TFL3 | |
| SSQLQMGQKKNSKQD | 421 | P28223 | |
| GNANLVFMLKRNSEQ | 2506 | Q12802 | |
| KICSGLSFQRKNQFM | 486 | Q9ULD4 | |
| QQLKDSGKSLSMFQQ | 3166 | Q96M86 | |
| GKLATFQNQIMKLEN | 531 | A6NI56 | |
| ELSLKMQGKNNDIFQ | 356 | Q8TCP9 | |
| CRQDTSFMKKNGQQL | 516 | Q14156 | |
| NQDKKNMLFSGTNIA | 201 | O14983 | |
| NQDKKNMLFSGTNIT | 201 | Q93084 | |
| QSLGSRNFIRNSKKM | 61 | Q96CP6 | |
| NNSGMNLLDQSVIKK | 186 | Q92481 | |
| RKQNQALNAMLIKGS | 1456 | Q96SN8 | |
| SMQGKRKALKLNFAN | 36 | P45985 | |
| EKNRAAAMANNLQKG | 231 | Q14498 | |
| NLGKTKDLSQNSNEM | 281 | P13056 | |
| NNATARVMTNKKTGN | 171 | A6NFN3 | |
| LSFSKGQLINVMNKD | 1146 | Q9NZM3 | |
| KIFRQMDTNNDGKLS | 151 | P84074 | |
| NGKFSTEFQRMKTLQ | 126 | Q2M385 | |
| QQRAFAGKTANKLMD | 386 | Q9UJX4 | |
| NQIMGYSRKDLQRNK | 1231 | Q9P2P5 | |
| RPFNALKTKNMRNLN | 261 | P33991 | |
| VLLKNGANKDMQNNR | 2046 | P46531 | |
| DQVKNGTNMKSLNLE | 3871 | Q86XX4 | |
| LRSFLMNSQHAKIKN | 736 | Q3T906 | |
| FQNLSLLIEQMKKNG | 1251 | Q2M2H8 | |
| LNFRNGSVIVNSKMK | 626 | Q17R60 | |
| RSQSEMLNSVNKNKF | 1866 | Q8IYD8 | |
| SQKFDNRGRKMSLNA | 1626 | Q8IY21 | |
| MNYIIGKNKNSRLAQ | 151 | Q96A33 | |
| RKNITDQQKFMGSSL | 4246 | Q9Y6V0 | |
| AQNIFLSKNGMVAKL | 131 | Q6P3R8 | |
| KIFRQMDTNNDGKLS | 151 | P37235 | |
| NSAQSNGTLMKEKQQ | 1611 | Q9Y4C0 | |
| LGSTEERKNMQRNKQ | 51 | Q15438 | |
| MNKSDLNTNNLLFKP | 316 | Q8IZD2 | |
| QRKSGSLQIKNRNHM | 321 | A6NHS7 | |
| NMALGKKAADSLQQN | 401 | Q1ED39 | |
| SKFDNNGNRDRMKLT | 326 | P05771 | |
| GNLQYNISRNTKMKS | 151 | A6NDL7 | |
| KRRAQMTKYLQSNSN | 1601 | Q7Z6Z7 | |
| VSNMRKLGHLNNFTK | 51 | Q6R327 | |
| ILLQSAKNNLKNMAF | 336 | Q8IZP7 | |
| ANMKKREGTQLSSQQ | 1381 | Q460N5 | |
| SGKDIMTQQLNSKNL | 986 | Q66GS9 | |
| YMNNAGKKERSNTLN | 346 | Q9UI47 | |
| LRMNFKQELNGNTKS | 3436 | P04114 | |
| NQDKKNMLFSGTNIA | 201 | P16615 | |
| FMKGNQLISNNIKFK | 646 | P51797 | |
| ALRVMTNKLKNAYNG | 466 | Q9Y625 | |
| IFLGNNNQAMKATKE | 551 | Q8N1I0 | |
| SLLMNGLRNNQRKAK | 226 | P19525 | |
| NKGNFLEMKNKFLAR | 1781 | Q12873 | |
| KANMFRSQVTGKINL | 426 | P16671 | |
| RNLQAAKMAQEKSFG | 446 | Q8NCL4 | |
| KQDLGIKQFSLMREN | 1846 | Q8N3K9 | |
| EANEGSKTLQRNRKM | 51 | Q99418 | |
| KRTKGLMNRNATLSQ | 196 | Q9NRY5 | |
| GYLQNSKNKRTQNMA | 2531 | Q99698 | |
| RNMTLKDGKNNVAIA | 551 | Q96RQ3 | |
| KEGMLTKQNNSFQRS | 56 | Q16760 | |
| KQAFGIMNELRLSQQ | 61 | Q14145 | |
| NQGSLAQGKNFLMSK | 766 | Q9Y2H2 | |
| SNLKKQIENARMFGI | 736 | P11586 | |
| MGTSKNGFNENRQKR | 36 | Q3ZCN5 | |
| NQASRKGQLVQKESM | 361 | Q16363 | |
| SSFNGKMNALNEVNK | 346 | Q93008 | |
| FSENKLQLKQMGDQL | 5966 | Q8WXH0 | |
| LQLKQMGDQLIKASN | 5971 | Q8WXH0 | |
| TIISQLLKNNMNKNG | 91 | Q92786 | |
| NAFQRDTFKGLKNLM | 181 | O60938 | |
| QKKVSRFNLQMDISG | 66 | Q7Z3Q1 | |
| MEGTSSKNKQLRNDF | 601 | Q8TCU6 | |
| KRNLTNGLNANMGFQ | 766 | Q6P3W7 | |
| LNMKFKAEVQSNRGL | 511 | P51692 | |
| AGRKMSLRNKGNVQN | 316 | Q16533 | |
| LNMKFKAEVQSNRGL | 511 | P42229 | |
| NNRQLKKDGDMTAFN | 471 | Q9NRA8 | |
| GMNFLEKRALNIKQN | 111 | Q9BWT1 | |
| NGFNSLLNNMELIRK | 221 | Q9UJS0 | |
| RQGAKTVFNKFSNMN | 136 | Q7L1S5 | |
| QKFLAQNRKNTSFML | 71 | Q96PP4 | |
| ASLMGQLQNIAKKEN | 406 | Q8WWU5 | |
| GFKASNNRLFQLVMK | 186 | O94967 | |
| GKKMSCQQFIANLDQ | 426 | Q9BQI7 | |
| AQIKNLMSQLGTKQD | 41 | Q86Y82 | |
| SRKFNILGTNTKVMN | 381 | P40763 | |
| NLIKMNKSLNRNQGL | 256 | O95171 | |
| DNKFRLLTQMSAGKQ | 96 | Q86SZ2 | |
| QQKLTDKNLGFQMLQ | 1006 | Q8IX01 | |
| GSKMQKNDFHRNLTT | 296 | P80108 | |
| QNFRKNQKGIMRQTS | 156 | O94885 | |
| IGLNMLSNNKKLSEN | 106 | Q9GZR1 | |
| RKARMKDQFGNSIIN | 401 | Q9GZR1 | |
| RAVSKNKPLLNSMNF | 1496 | Q9P273 | |
| QKRSNNFPFQGKSIM | 271 | Q658L1 | |
| GLRSKMAIQTQQSKF | 171 | O96008 | |
| LGMNLMNELKQNFSK | 71 | Q16890 | |
| LSAANQKEPMNLNFK | 581 | Q17R98 | |
| FTKLNEVNLSMQGKN | 481 | Q49AG3 | |
| GKNLRQMSKDYQQVL | 86 | Q96BZ9 | |
| SGQQENLNSMKKRNV | 2426 | Q9BXT5 | |
| NLNSMKKRNVNFSAA | 2431 | Q9BXT5 | |
| QKNMFLRSFLGQLAK | 801 | Q9NYU1 | |
| VDANQKSVLGRNFKM | 1076 | Q96QU8 | |
| SLANLNLNNMLDKKA | 21 | P47974 | |
| QQLLSAMNKQRGSKA | 2096 | Q6PIF6 | |
| KNSRRMLSNKPQDFQ | 186 | Q9NZM1 |